Contrasting Integrated BioPharma (OTCMKTS:INBP) and NovAccess Global (OTCMKTS:XSNX)

Institutional and Insider Ownership

25.3% of Integrated BioPharma shares are held by institutional investors. 1.4% of NovAccess Global shares are held by company insiders. Comparatively, 67.2% of Integrated BioPharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Profitability

This table compares NovAccess Global and Integrated BioPharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NovAccess Global	N/A	N/A	-1,723.92%
Integrated BioPharma	0.84%	2.26%	1.64%

Risk & Volatility

NovAccess Global has a beta of 2.19, indicating that its stock price is 119% more volatile than the S&P 500. Comparatively, Integrated BioPharma has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500.

Earnings & Valuation

This table compares NovAccess Global and Integrated BioPharma”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NovAccess Global	N/A	N/A	-$4.72 million	($0.11)	0.00
Integrated BioPharma	$50.32 million	0.23	$110,000.00	$0.02	19.01

Integrated BioPharma has higher revenue and earnings than NovAccess Global. NovAccess Global is trading at a lower price-to-earnings ratio than Integrated BioPharma, indicating that it is currently the more affordable of the two stocks.

Summary

Integrated BioPharma beats NovAccess Global on 8 of the 9 factors compared between the two stocks.

About NovAccess Global

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

About Integrated BioPharma

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.